Inactivation of mTORC2 in macrophages is a signature of colorectal cancer that promotes tumorigenesisKarl Katholnig(Institute of Genetics), Thomas Weichhart(Medical University of Vienna)JCI InsightOctober 16, 201910.1172/jci.insight.124164Cited by 27SaveCiteExport RISWatch citationsRelated PapersInhibition of mTOR blocks the anti-inflammatory effects of glucocorticoids in myeloid immune cells|Blood|2011|141Metabolic support by macrophages sustains colonic epithelial homeostasis|Cell Metabolism|2023|87p38 regulates the tumor suppressor PDCD4 via the TSC-mTORC1 pathway|Cell Stress|2021|7